These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7489343

  • 1. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
    Negro F, Abate ML, Mondardini A, Baldi M, Leandro G, Lombardi S, Wolfe L, Ryff JC, Verme G, Brunetto MR.
    J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
    Garcia-Valdecasas J, Bernal C, Cerezo S, Garcia F, Montiel N, Leyva A, Umana WO, Bosch JP.
    ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA, van Binsbergen J, Wang CY, Pardo M, Navas S, Trines C, Herrero M, Carreño V.
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Significance of IgM anti-HCV core level in chronic hepatitis C.
    Papatheodoridis GV, Delladetsima JK, Katsoulidou A, Sypsa V, Albrecht M, Michel G, Hatzakis A, Tassopoulos NC.
    J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
    Quiroga JA, Herrero M, Castillo I, Navas S, Pardo M, Carreño V.
    J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
    [Abstract] [Full Text] [Related]

  • 12. Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares.
    Ciccorossi P, Filipponi F, Oliveri F, Campani D, Colombatto P, Bonino F, Campa M, Maltinti G, Mosca F, Brunetto MR.
    J Viral Hepat; 2003 May; 10(3):168-73. PubMed ID: 12753334
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
    Saracco G, Abate ML, Baldi M, Calvo PL, Manzini P, Brunetto MR, Oliveri F, Kuo G, Chien D, Houghton M.
    Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
    [Abstract] [Full Text] [Related]

  • 15. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
    Urushihara A, Sodeyama T, Matsumoto A, Tanaka E.
    J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
    [Abstract] [Full Text] [Related]

  • 16. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
    Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, Bonino F, Gentilini P.
    Arch Virol; 1997 Apr; 142(3):535-44. PubMed ID: 9349299
    [Abstract] [Full Text] [Related]

  • 17. Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study.
    Flichman D, Colombatto P, Randone A, Baldi M, Bellati G, Negro F, Oliveri F, Colucci G, Verme G, Bonino F, Brunetto MR.
    Clin Diagn Virol; 1997 May; 8(1):63-70. PubMed ID: 9248659
    [Abstract] [Full Text] [Related]

  • 18. IgM antibody response to the hepatitis C virus core protein in intravenous drug users.
    Toniutto P, Falleti E, Gasparini V, Fabris C, Tisminetzky SG, Lombardelli T, Pacco P, Satta A, Pirisi M.
    Diagn Microbiol Infect Dis; 1999 Feb; 33(2):69-73. PubMed ID: 10091028
    [Abstract] [Full Text] [Related]

  • 19. Levels of hepatitis C virus (HCV) RNA in serum and their relationship to levels of immunoglobulin M and G antibodies against HCV core protein.
    Chen M, Sönnerborg A, Sällberg M.
    J Clin Microbiol; 1995 Mar; 33(3):778-80. PubMed ID: 7538513
    [Abstract] [Full Text] [Related]

  • 20. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
    Kusaka S, Okusa T, Araki A, Fujiki K, Takashimizu I, Okayasu I, Yamamoto N, Sato C.
    J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.